Ultragenyx Pharmaceutical Inc. vs UnitedHealth Group Incorporated — Stock Comparison
Q·Score Breakdown
5.2
Bearish
Overall
6.3
Neutral
Quality
Health
Growth
Valuation
Sentiment
RARE
90% of 20 covering analysts have a positive rating.
⚠ currently unprofitable (-85% margin).
UNH
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
Analyst Consensus
BUY
Target $53.35 (+115.4%)
20 analysts
BUY
Target $387.27 (+5.0%)
26 analysts
Fundamentals
RARE
UNH
—
Trailing P/E
27.9×
-1945.8×
Forward P/E
17.8×
-85.4%
Profit Margin
2.7%
-27.6%
Gross Margin
18.8%
-608.5%
ROE
12.2%
25.9%
Revenue Growth
2.0%
—
Earnings Growth
0.7%
0.25
Beta
0.41
—
Price / Book
—
$2.4B
Market Cap
$334.9B
$18 – $42
52-Week Range
$235 – $410
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →